Acquisition

After a massive divestiture, Vistance Networks reports soaring growth, zero debt, and plans a huge special cash distribution to its shareholders.

After a strong 2025, Viatris unveils a plan for $650M in savings, a 10% workforce cut, and a focus on six new drugs to fuel future innovation.

Vistra posts record 2025 results and a bullish 2026 forecast, fueled by major acquisitions and landmark nuclear power deals with tech titans AWS and Meta.

After strong 2025 results, the infrastructure supplier is building a new US factory to capitalize on grid modernization, offsetting softer lumber markets.

As AI data centers grow more complex, a new wave of intelligent management tools emerges. KAYTUS's KSManage promises to shift from reactive fixes to predictive foresight.

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

India's Tejas Networks will supply 5G radios to Japan's NEC, a deal signaling a major shift in global supply chains and a win for open network standards.

The environmental services giant surpassed 2025 targets, driven by its GreenUp strategy, major acquisitions in water tech, and a renewed global push.

Fujitsu's 1Finity launches its L1000/L2000 platform, promising to power AI's data demands with an open, cost-cutting optical network architecture.

The therapy giant reports robust revenue growth and record patient visits, backed by major acquisitions and new 10-year hospital system alliances.

Engineering giant Stantec reports a landmark year with $6.5B revenue, hitting strategic targets early, and raises its dividend, signaling strong future growth.

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

The real estate giant announced a take-private merger led by its CEO alongside results showing major growth from its Toll Brothers platform acquisition.

The building products giant posted Q4 losses but its multi-billion-dollar acquisition spree and tech focus signal a radical reshaping of the industry.

Crescent's record production and strategic acquisitions paint a complex picture for investors amid a significant earnings beat but a notable revenue miss.

The biopharma company shatters records with 51% growth in its key drug, ASCENIV, and outlines a strategic overhaul aimed at long-term market dominance.

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.

FTAI Aviation reports a massive profit turnaround and raises its dividend, signaling confidence. But a pivot to power generation may be the real story.

Riding a wave of AI-focused innovation, Everpure smashes records with its first billion-dollar quarter, signaling a new era in data intelligence.